Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04266041 · ClinicalTrials.gov registry record · NA

High-density EEG in Neurological Disorders

A NA study of Healthy and Epilepsy, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
122
Enrollment target
1
Study location

NCT04266041 is a NA study of Healthy and Epilepsy that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 122 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04266041, a NA study of Healthy and Epilepsy, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to use a new method of high-density electroencephalogram (HD-EEG) recording to map brain areas important for movement, sensation, language, emotion, and cognition.

Interventions

  • DIAGNOSTIC_TEST High-density electroencephalogram (HD-EEG)

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2018-02-09
Est. Completion 2024-12-13
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT04266041

The ClinicalTrials.gov registry entry for NCT04266041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which High-density electroencephalogram (HD-EEG) is the first listed.

NCT04266041 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT04266041 about?

NCT04266041 is a clinical study titled "High-density EEG in Neurological Disorders". The purpose of the study is to use a new method of high-density electroencephalogram (HD-EEG) recording to map brain areas important for movement, sensation, language, emotion, and cognition.

What is the current status of trial NCT04266041?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2018-02-09. Estimated completion is 2024-12-13.

What conditions does trial NCT04266041 study?

This clinical trial studies the following conditions: Healthy, Epilepsy, Tumor.

What interventions are being tested in trial NCT04266041?

The interventions under investigation include: High-density electroencephalogram (HD-EEG) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04266041?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04266041 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.